Virtual Reality-Based Exercise in Cancer Patients

Distorted; Balance Clinical Trial

Official title:

Virtual Reality-Based Exercise in Cancer Patients With Chemotherapy Induced Peripheral Neuropathy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02165163
• Other study ID #: iCAMP_123
• Status: Completed
• Phase: N/A
• First received: June 13, 2014
• Last updated: May 21, 2015
• Start date: September 2013
• Est. completion date: August 2014

Study information

• Verified date: May 2015
• Source: University of Arizona
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The aim of the present study is to evaluate an innovative virtual reality-based balance training intervention for improving clinically relevant motor performances (balance and gait) in cancer patients.

The investigators hypothesize that the virtual reality-based balance training intervention will improve balance and gait performances in cancer patients compared to a control group receiving usual care only.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 20
• Est. completion date: August 2014
• Est. primary completion date: August 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• ability to ambulate without assistance

• willingness to provide informed consent

• cancer

• neuropathy related to chemotherapy

Exclusion Criteria:

• severe neurologic, cardiovascular, metabolic, or psychiatric disorders

• severe visual impairment

• cognitive impairment

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Distorted; Balance
• Motor Deficit

Intervention

Other:
• Balance Training
Balance training will be conducted individually two times per week for 4 weeks. Each training session will include virtual reality tasks such as "ankle reaching" and "obstacle crossing" using a virtual obstacle shown on a computer screen. Each session will last 30 - 45 minutes.

Locations

Country	Name	City	State
United States	University of Arizona Cancer Center	Tucson	Arizona

Sponsors (1)

Lead Sponsor	Collaborator
University of Arizona

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postural Balance	Postural Balance during quiet standing for 30 seconds will be assessed using validated wearable sensor technologies (BalanSens™)	after 4 weeks	No
Secondary	Gait performance	Gait performance will be measured using validated wearable sensor technology (LEGSys™)	4 weeks	No